GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 89 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $14,953,000 | +1.2% | 1,552,740 | +24.4% | 1.60% | +3.3% |
| Q2 2017 | $14,770,000 | +7.0% | 1,248,508 | +15.9% | 1.55% | +2.7% |
| Q1 2017 | $13,810,000 | +31.3% | 1,077,196 | +25.4% | 1.51% | +44.0% |
| Q4 2016 | $10,518,000 | -36.3% | 859,349 | -38.5% | 1.05% | -38.8% |
| Q3 2016 | $16,500,000 | +25.4% | 1,398,288 | -7.6% | 1.71% | +10.0% |
| Q2 2016 | $13,161,000 | +149.2% | 1,512,734 | +50.9% | 1.56% | +137.0% |
| Q1 2016 | $5,282,000 | -44.8% | 1,002,262 | -17.6% | 0.66% | -47.9% |
| Q4 2015 | $9,574,000 | 0.0% | 1,216,481 | 0.0% | 1.26% | +0.8% |
| Q3 2015 | $9,574,000 | – | 1,216,481 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |